SCHEMBL4139370

SCHEMBL4139370

NC(=O)[C@@H]1C[C@H]1c1ccccc1F

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.56
KDM1B Q8NB78 1/20 0.56
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
SLC9A1 P19634 2/20 0.45
GPR88 Q9GZN0 1/20 0.43
GAA P10253 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.39
GFER P55789 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
KCNN4 O15554 2/20 0.38
PRCP P42785 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
CXCR2 P25025 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4139367 1.00 KDM1A (0.56) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL31701500 1.00 KDM1A (0.56) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL15541112 1.00 KDM1A (0.56) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL15541759 1.00 KDM1A (0.56) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL15797923 0.84 KDM1A (0.53) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL5675799 0.84 KDM1A (0.53) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL32677643 0.84 KDM1A (0.53) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL4133939 0.84 KDM1A (0.53) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL3420686 0.84 KDM1A (0.53) KDM1AKDM1BHTR2CHTR2BSLC9A1
SCHEMBL31076255 0.84 KDM1A (0.53) KDM1AKDM1BHTR2CHTR2BSLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents HTR2C, HTR2A, HTR5A KDM1A 3105/4885KDM1B 2333/4885HTR2C 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.